Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance.

Weissfeld JL, Liu W, Woods C, Zhang R, Li J, van der Vlugt TH, Slaughter SR.

Menopause. 2018 Jun;25(6):611-614. doi: 10.1097/GME.0000000000001054.

PMID:
29286985
2.

Pesticide exposure and liver cancer: a review.

VoPham T, Bertrand KA, Hart JE, Laden F, Brooks MM, Yuan JM, Talbott EO, Ruddell D, Chang CH, Weissfeld JL.

Cancer Causes Control. 2017 Mar;28(3):177-190. doi: 10.1007/s10552-017-0854-6. Epub 2017 Feb 13. Review.

3.

A prospective and retrospective analysis of smoking behavior changes in ever smokers with high risk for lung cancer from New Mexico and Pennsylvania.

Leng S, Weissfeld JL, Picchi MA, Styn MA, Claus ED, Clark VP, Wu G, Thomas CL, Gilliland FD, Yuan J, Siegfried JM, Belinsky SA.

Int J Mol Epidemiol Genet. 2016 Jun 1;7(2):95-104. eCollection 2016.

4.

Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.

Siegfried JM, Lin Y, Diergaarde B, Lin HM, Dacic S, Pennathur A, Weissfeld JL, Romkes M, Nukui T, Stabile LP.

Neoplasia. 2015 Nov;17(11):817-25. doi: 10.1016/j.neo.2015.11.002.

5.

Pesticide exposure and hepatocellular carcinoma risk: A case-control study using a geographic information system (GIS) to link SEER-Medicare and California pesticide data.

VoPham T, Brooks MM, Yuan JM, Talbott EO, Ruddell D, Hart JE, Chang CC, Weissfeld JL.

Environ Res. 2015 Nov;143(Pt A):68-82. doi: 10.1016/j.envres.2015.09.027. Epub 2015 Oct 8.

6.

Lung Cancer Risk Prediction Using Common SNPs Located in GWAS-Identified Susceptibility Regions.

Weissfeld JL, Lin Y, Lin HM, Kurland BF, Wilson DO, Fuhrman CR, Pennathur A, Romkes M, Nukui T, Yuan JM, Siegfried JM, Diergaarde B.

J Thorac Oncol. 2015 Nov;10(11):1538-45. doi: 10.1097/JTO.0000000000000666.

7.

Linking pesticides and human health: a geographic information system (GIS) and Landsat remote sensing method to estimate agricultural pesticide exposure.

VoPham T, Wilson JP, Ruddell D, Rashed T, Brooks MM, Yuan JM, Talbott EO, Chang CH, Weissfeld JL.

Appl Geogr. 2015 Aug;62:171-181. doi: 10.1016/j.apgeog.2015.04.009. Epub 2015 May 18.

8.

Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.

Tessema M, Yingling CM, Picchi MA, Wu G, Liu Y, Weissfeld JL, Siegfried JM, Tesfaigzi Y, Belinsky SA.

J Thorac Oncol. 2015 Aug;10(8):1181-8. doi: 10.1097/JTO.0000000000000592.

9.

Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.

Thalanayar PM, Altintas N, Weissfeld JL, Fuhrman CR, Wilson DO.

Ann Am Thorac Soc. 2015 Aug;12(8):1193-6. doi: 10.1513/AnnalsATS.201412-577OC.

10.

Differential expression of circulating microRNAs according to severity of colorectal neoplasia.

Ho GYF, Jung HJ, Schoen RE, Wang T, Lin J, Williams Z, Weissfeld JL, Park JY, Loudig O, Suh Y.

Transl Res. 2015 Sep;166(3):225-232. doi: 10.1016/j.trsl.2015.02.004. Epub 2015 Feb 23.

11.

15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers.

Leng S, Liu Y, Weissfeld JL, Thomas CL, Han Y, Picchi MA, Edlund CK, Willink RP, Gaither Davis AL, Do KC, Nukui T, Zhang X, Burki EA, Van Den Berg D, Romkes M, Gauderman WJ, Crowell RE, Tesfaigzi Y, Stidley CA, Amos CI, Siegfried JM, Gilliland FD, Belinsky SA.

J Natl Cancer Inst. 2015 Feb 23;107(5). pii: djv035. doi: 10.1093/jnci/djv035.

12.

Improving selection criteria for lung cancer screening. The potential role of emphysema.

Sanchez-Salcedo P, Wilson DO, de-Torres JP, Weissfeld JL, Berto J, Campo A, Alcaide AB, Pueyo J, Bastarrika G, Seijo LM, Pajares MJ, Pio R, Montuenga LM, Zulueta JJ.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):924-31. doi: 10.1164/rccm.201410-1848OC.

13.

Human herpesvirus 8 seroconversion in a population-based cohort of men in Tobago.

McDonald AC, Jenkins FJ, Bunker CH, Wilson JW, Patrick AL, Weissfeld JL.

J Med Virol. 2015 Apr;87(4):642-7. doi: 10.1002/jmv.24128. Epub 2015 Jan 21.

PMID:
25612304
14.

Incidence of head and neck squamous cell carcinoma among subjects at high risk of lung cancer: results from the Pittsburgh Lung Screening Study.

Dixit R, Weissfeld JL, Wilson DO, Balogh P, Sufka P, Siegfried JM, Grandis JR, Diergaarde B.

Cancer. 2015 May 1;121(9):1431-5. doi: 10.1002/cncr.29189. Epub 2015 Jan 5.

15.

Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.

de-Torres JP, Wilson DO, Sanchez-Salcedo P, Weissfeld JL, Berto J, Campo A, Alcaide AB, GarcĂ­a-Granero M, Celli BR, Zulueta JJ.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):285-91. doi: 10.1164/rccm.201407-1210OC.

16.

Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.

Fung C, Zhou P, Joyce S, Trent K, Yuan JM, Grandis JR, Weissfeld JL, Romkes M, Weeks DE, Egloff AM.

Cancer Lett. 2015 Feb 28;357(2):549-56. doi: 10.1016/j.canlet.2014.12.008. Epub 2014 Dec 12.

17.

Prognosis and conditional disease-free survival among patients with ovarian cancer.

Kurta ML, Edwards RP, Moysich KB, McDonough K, Bertolet M, Weissfeld JL, Catov JM, Modugno F, Bunker CH, Ness RB, Diergaarde B.

J Clin Oncol. 2014 Dec 20;32(36):4102-12. doi: 10.1200/JCO.2014.55.1713. Epub 2014 Nov 17.

18.

Inherited variation in the ATP-binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer.

Weissfeld JL, Diergaarde B, Nukui T, Buch S, Pennathur A, Socinski MA, Siegfried JM, Romkes M.

J Thorac Oncol. 2014 Sep;9(9):1264-71. doi: 10.1097/JTO.0000000000000262.

19.

Validation of a blood protein signature for non-small cell lung cancer.

Mehan MR, Williams SA, Siegfried JM, Bigbee WL, Weissfeld JL, Wilson DO, Pass HI, Rom WN, Muley T, Meister M, Franklin W, Miller YE, Brody EN, Ostroff RM.

Clin Proteomics. 2014 Aug 1;11(1):32. doi: 10.1186/1559-0275-11-32. eCollection 2014.

20.

COPD phenotypes in a lung cancer screening population.

Balkan A, Bulut Y, Fuhrman CR, Fisher SN, Wilson DO, Weissfeld JL, Sciurba FC.

Clin Respir J. 2016 Jan;10(1):48-53. doi: 10.1111/crj.12180. Epub 2014 Jul 28.

PMID:
24989058
21.

Dietary iron, iron homeostatic gene polymorphisms and the risk of advanced colorectal adenoma and cancer.

Ruder EH, Berndt SI, Gilsing AM, Graubard BI, Burdett L, Hayes RB, Weissfeld JL, Ferrucci LM, Sinha R, Cross AJ.

Carcinogenesis. 2014 Jun;35(6):1276-83. doi: 10.1093/carcin/bgu028. Epub 2014 Feb 17.

22.

Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial.

Felix AS, Weissfeld JL, Pfeiffer RM, Modugno F, Black A, Hill LM, Martin J, Sit AS, Sherman ME, Brinton LA.

Int J Cancer. 2014 Feb 15;134(4):954-60. doi: 10.1002/ijc.28404. Epub 2013 Aug 28.

23.

Characteristics and survival of patients with invasive amelanotic melanoma in the USA.

Moreau JF, Weissfeld JL, Ferris LK.

Melanoma Res. 2013 Oct;23(5):408-13. doi: 10.1097/CMR.0b013e32836410fe.

PMID:
23883947
24.

Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.

Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR.

Head Neck Pathol. 2013 Dec;7(4):344-55. doi: 10.1007/s12105-013-0447-y. Epub 2013 May 4.

25.

Childhood passive smoke exposure is associated with adult head and neck cancer.

Troy JD, Grandis JR, Youk AO, Diergaarde B, Romkes M, Weissfeld JL.

Cancer Epidemiol. 2013 Aug;37(4):417-23. doi: 10.1016/j.canep.2013.03.011. Epub 2013 Apr 22.

26.

Genetic variation in ESR2 and estrogen receptor-beta expression in lung tumors.

Song JY, Siegfried JM, Diergaarde B, Land SR, Bowser R, Stabile LP, Dacic S, Dhir R, Nukui T, Romkes M, Weissfeld JL.

Cancer Epidemiol. 2013 Aug;37(4):518-22. doi: 10.1016/j.canep.2013.03.020. Epub 2013 Apr 23.

27.

Erythrocyte omega-6 and omega-3 fatty acids and mammographic breast density.

Hudson AG, Reeves KW, Modugno F, Wilson JW, Evans RW, Vogel VG, Gierach GL, Simpson J, Weissfeld JL.

Nutr Cancer. 2013;65(3):410-6. doi: 10.1080/01635581.2013.760744.

28.

CYP2A6 genotype and smoking behavior in current smokers screened for lung cancer.

Styn MA, Nukui T, Romkes M, Perkins KA, Land SR, Weissfeld JL.

Subst Use Misuse. 2013 May;48(7):490-4. doi: 10.3109/10826084.2013.778280. Epub 2013 Mar 25.

29.

Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.

Troy JD, Weissfeld JL, Diergaarde B, Youk AO, Buch SC, Romkes M, Grandis JR.

Cancer Epidemiol. 2013 Aug;37(4):505-11. doi: 10.1016/j.canep.2013.02.009. Epub 2013 Mar 21.

30.

The effect of stent post-dilation in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction.

Zhang ZJ, Marroquin OC, Stone RA, Weissfeld JL, Mulukutla SR, Selzer F, Kip KE.

Heart Lung Circ. 2013 Sep;22(9):787-8. doi: 10.1016/j.hlc.2012.11.012. Epub 2013 Jan 5. No abstract available.

PMID:
23294761
31.

Retraction. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.

Schoen RE, Weissfeld JL, Sokoll LJ, Chan DW, Cannon GW, Getzenberg RH.

Cancer Res. 2013 Jan 15;73(2):1034. doi: 10.1158/0008-5472.CAN-12-3286. Epub 2012 Dec 27. No abstract available.

32.

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Bandos H, Weissfeld JL, Wolmark N.

Cancer Prev Res (Phila). 2012 Nov;5(11):1321-9. doi: 10.1158/1940-6207.CAPR-12-0273. Epub 2012 Oct 11.

33.

Prospective study of genomic hypomethylation of leukocyte DNA and colorectal cancer risk.

Huang WY, Su LJ, Hayes RB, Moore LE, Katki HA, Berndt SI, Weissfeld JL, Yegnasubramanian S, Purdue MP.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2014-21. doi: 10.1158/1055-9965.EPI-12-0700-T. Epub 2012 Sep 20.

34.

Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1282-92. doi: 10.1158/1055-9965.EPI-12-0426. Epub 2012 Jun 15.

35.

Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.

Hazelton WD, Goodman G, Rom WN, Tockman M, Thornquist M, Moolgavkar S, Weissfeld JL, Feng Z.

Math Biosci. 2012 Nov;240(1):20-34. doi: 10.1016/j.mbs.2012.05.008. Epub 2012 Jun 15.

36.

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.

Felix AS, Edwards RP, Stone RA, Chivukula M, Parwani AV, Bowser R, Linkov F, Weissfeld JL.

Br J Cancer. 2012 Jun 5;106(12):2004-9. doi: 10.1038/bjc.2012.200. Epub 2012 May 22.

37.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.

38.

Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer.

Gilsing AM, Berndt SI, Ruder EH, Graubard BI, Ferrucci LM, Burdett L, Weissfeld JL, Cross AJ, Sinha R.

Carcinogenesis. 2012 Jul;33(7):1332-9. doi: 10.1093/carcin/bgs158. Epub 2012 May 2.

39.

A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.

Bigbee WL, Gopalakrishnan V, Weissfeld JL, Wilson DO, Dacic S, Lokshin AE, Siegfried JM.

J Thorac Oncol. 2012 Apr;7(4):698-708. doi: 10.1097/JTO.0b013e31824ab6b0.

40.

Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Hickey T, Riley T, Prorok PC.

Gastrointest Endosc. 2012 Mar;75(3):612-20. doi: 10.1016/j.gie.2011.10.024.

PMID:
22341106
41.

Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.

Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, Weissfeld JL, Wolmark N.

Cancer Prev Res (Phila). 2012 Apr;5(4):583-92. doi: 10.1158/1940-6207.CAPR-11-0482. Epub 2012 Feb 7.

42.

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team.

J Natl Cancer Inst. 2012 Feb 22;104(4):280-9. doi: 10.1093/jnci/djr549. Epub 2012 Jan 31.

43.

Serum biomarker profiles as diagnostic tools in lung cancer.

Nolen BM, Langmead CJ, Choi S, Lomakin A, Marrangoni A, Bigbee WL, Weissfeld JL, Wilson DO, Dacic S, Siegfried JM, Lokshin AE.

Cancer Biomark. 2011-2012;10(1):3-12. doi: 10.3233/CBM-2012-0229.

44.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.

J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.

45.

Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer.

Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM.

Hypertension. 2012 Feb;59(2):205-11. doi: 10.1161/HYPERTENSIONAHA.111.171736. Epub 2011 Dec 19.

PMID:
22184319
46.

A case-cohort study of human herpesvirus 8 seropositivity and incident prostate cancer in Tobago.

McDonald AC, Jenkins FJ, Bunker CH, Wilson JW, Patrick AL, Weissfeld JL.

Infect Agent Cancer. 2011 Dec 7;6:25. doi: 10.1186/1750-9378-6-25.

47.

Factors associated with mortality after breast cancer metastasis.

Jung SY, Rosenzweig M, Sereika SM, Linkov F, Brufsky A, Weissfeld JL.

Cancer Causes Control. 2012 Jan;23(1):103-12. doi: 10.1007/s10552-011-9859-8. Epub 2011 Oct 29.

PMID:
22037907
48.

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Rathmell JM, Riley TL, Wright P, Caparaso N, Hu P, Izmirlian G, Pinsky PF, Prorok PC, Kramer BS, Miller AB, Gohagan JK, Berg CD; PLCO Project Team.

JAMA. 2011 Nov 2;306(17):1865-73. doi: 10.1001/jama.2011.1591. Epub 2011 Oct 26.

PMID:
22031728
49.

Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.

Felix AS, Stone RA, Chivukula M, Bowser R, Parwani AV, Linkov F, Edwards RP, Weissfeld JL.

Int J Cancer. 2012 Jul 15;131(2):E114-21. doi: 10.1002/ijc.27317. Epub 2012 Jan 3.

50.

Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer.

Buch SC, Diergaarde B, Nukui T, Day RS, Siegfried JM, Romkes M, Weissfeld JL.

Mol Carcinog. 2012 Oct;51 Suppl 1:E11-20. doi: 10.1002/mc.20858. Epub 2011 Oct 4.

Supplemental Content

Loading ...
Support Center